Asthma Spacers Market Forecast, Trend Analysis & Competition Tracking - Global Industry Insights 2015 to 2031

A spacer is a holding chamber shaped such as a tube. The spacers help deliver the medication directly to the lungs, with less medicine in the mouth and throat that may lead to mild infections. The asthma spacer is very helpful in taking asthma or COPD medication from the type of puffer called a metered-dose inhaler (MDI).

Request Covid - 19 Impact

Demand For Asthma Spacers From 2015 To 2020 Vs Future Market Projections For 2021-2031

From 2015 to 2020, sales of asthma spacers were significantly high, expanding at under 5.5% CAGR. This is due to increasing government and private agencies' investment in preventing and treating various respiratory diseases.

There is a sudden uprise in demand for asthma spacers, owing to the increasing number of COVID-19 cases with respiratory symptoms, and many patients have developed acute respiratory disease syndrome (ARDS). Also, people with asthma (PWA) are at high risk of serious illness from COVID-19.

Global Asthma Spacers Market Revenue Outlook:

The Global Asthma Spacers Market was valued at US$ 1.5 Bn in 2020 and is projected to register а САGR of 5.8% by 2031.

Nonetheless, various industry players in the global asthma spacers market are now increasing their focus on establishing successful collaborations, acquisitions, and joint venture activities to enhance their respective customer bases. In doing so, these players are also growing their supply capabilities to meet customer requirements on a local and global scale. This factor, paired with promising industrialization prospects in developing economies of the Asia-Pacific region, such as China, India, Taiwan, Indonesia, etc., are expected to create massive business opportunities for key players over the forecast period.

The Increasing Prevalence Of Respiratory Diseases And Disorders Is Expected To Have A Positive Effect On The Market

The increasing prevalence of respiratory diseases and disorders such as asthma, COPD, and others in countries across the globe is expected to drive the growth of the global market to a significant extent over the forecast period. Rising indoor and outdoor air pollution levels, primarily due to rapid industrialization, unhealthy diet and food consumption habits and patterns, and physical inactivity, are among other factors that can potentially cause respiratory diseases.

• According to a recent report for Global Burden of Disease Study, 251 Mn cases of Chronic Obstructive Pulmonary Disease (COPD) were recorded. In addition, over 90% of deaths due to COPD occurred in middle and low-income countries. The number of cases of COPD is expected to increase further due to the rising number of individuals smoking tobacco and increasing the geriatric population globally.

World's Leading Causes Of Global Deaths In 2019 (Mn)

To learn more about this report, request for sample report

Lack Of Knowledge Regarding Usage Of Device And Administration Protocols May Hamper The Growth Of The Market

The focus of manufacturers on R&D activities and the development of technologically enhanced inhalers and spacers with different functions and operation procedures have been increasing to gain a competitive edge in the market. However, this is resulting in a lack or less understanding or knowledge regarding proper usage of such products. As a result of advancements, nurses, physicians, and therapists do not have sufficient knowledge regarding device usage and administration protocols. Lack of professional guidance to patients regarding a product or device usage and of practitioners can potentially limit adoption of products as well as the growth of the target market. Spacers are a bit time-consuming and difficult when the drug is required to be administered to children, patients who need special medication, and elderly individuals, which can further impact the adoption rate and market growth.

Combination Inhaler For The Treatment Of Respiratory Diseases

A key trend observed in the market currently is that patients with asthma are prescribed combination inhalers containing two types of medicine. These include a long-acting reliever (long-acting beta-agonists) that relieves ongoing symptoms, including tight chest and breathlessness. At the same time, a preventer is used to avert inflammation over the long term. Adopting combination inhalers for the treatment of various respiratory diseases is expected to gain rapid and steady traction over the forecast period. This is expected to positively impact spacers' demand, thereby supporting revenue growth of the target market shortly.

Market Analysis

The Global Asthma Spacers Market is segmented based on – Product Type, Distribution Channel, and Region. On the basis of Product Type, the aero chamber currently accounts for the largest revenue share in the global asthma spacers market, followed by optichamber. Concerning the distribution channel segment, the retail pharmacy segment is expected to account for a significant revenue share in the global market. The market asthma spacers are segmented region-wise into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, markets in North America are projected to continue to account for the majority revenue share. Similarly, each region included in this report is further segmented according to respective countries, revenues, economic growth rates, etc.

Competitive Landscape

The asthma spacers landscape appears highly consolidated, with a major chunk of it being dominated by below players.

• GlaxoSmithKline Plc.
• Truedell Medical International
• Cipla Inc.
• Medical Developments International
• PARI Respiratory Equipment, Inc.
• Koninklijke Philips N.V.
• Clement Clarke International Ltd.
• Lupin Limited
• Other Players

Report Scope

• Forecast Period: 2022-2031
• Actual Year: 2021
• Historical Data Available for: 2015-2020

Key Regions Covered

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Segments Covered

Asthma Spacers Market, By Product Type

• Aerochamber
• Optichamber
• Volumatic
• Inspirease

Asthma Spacers Market, By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• E-commerce

To learn more about this report, request for sample report

• GlaxoSmithKline Plc.
• Truedell Medical International
• Cipla Inc.
• Medical Developments International
• PARI Respiratory Equipment, Inc.
• Koninklijke Philips N.V.
• Clement Clarke International Ltd.
• Lupin Limited
• Other Players